Houlihan Lokey Advises MidEuropa

Houlihan Lokey is pleased to announce that MidEuropa has acquired a majority stake in MBL Group (MBL), a leading European contract development and manufacturing organisation (CDMO) for assisted mobility, rehabilitation, and aged care equipment. As part of the transaction, the INVL Baltic Sea Growth Fund has sold its entire stake, while the Lauritsen family has reinvested a significant amount and Martin Lauritsen will continue to lead the company as CEO. The transaction closed on 18 December 2025. Houlihan Lokey served as both the M&A and financing advisor on the transaction.

Founded in Denmark in 1988 by the Lauritsen family, MBL has grown into the largest European CDMO dedicated to medical mobility devices, including wheelchairs, rollators, aged-care beds, and other rehabilitation equipment.

With deep expertise across both individual component manufacturing and complete mobility solutions, MBL has built a highly differentiated, fully integrated platform combining in-house R&D, state-of-the-art manufacturing, and industry-leading reliability.

The company employs approximately 1,700 skilled professionals across manufacturing hubs in Europe and Asia, serving its global blue-chip clients, and holds more than 100 registered patents, underscoring its reputation for engineering excellence and innovation.

MidEuropa is a leading European private equity investor with deep roots in Central Europe and a track record spanning over 25 years. Headquartered in London, with offices in Warsaw and Bucharest, MidEuropa adopts a flexible pan-European and global approach to identify winning investments across the healthcare, technology, services, and consumer sectors and supports them in their growth and international expansion. To date, MidEuropa has raised and managed funds of more than €6.8 billion and completed 46 investments and over 290 add-on acquisitions across 20 countries.

This transaction highlights Houlihan Lokey’s leading European healthcare and medical technology focus, coupled with the firm’s debt capital solutions expertise in complex, cross-border transactions.

RELATED: Healthcare, Capital Solutions